We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 5,849

Sub-Prime Auto Loan Delinquencies Continue to Rise, but Experts Provide Divergent Views of Impact
  • Foley & Lardner LLP
  • USA
  • July 27 2017

Nearly one year ago, we wrote about auto loan delinquencies’ potential impact on the automotive industry. Now, car sales are falling and auto loan


Federal Circuit Finds Velcade Patent Not Obvious Under Lead Compound Analysis
  • Foley & Lardner LLP
  • USA
  • July 25 2017

In Millennium Pharmaceuticals, Inc. v. Sandoz, the Federal Circuit reversed the district court decision that invalidated one of the Orange


Back to Basics: A Review of Recent SCOTUS Personal Jurisdiction Jurisprudence
  • Foley & Lardner LLP
  • USA
  • July 25 2017

As its term drew to a close, the Supreme Court handed down its latest decision on personal jurisdiction in a case entitled Bristol-Myers Squibb Co. v


Trump Department of Justice Reverses Course on Class Action Waivers
  • Foley & Lardner LLP
  • USA
  • July 24 2017

On June 16, 2017, the United States Department of Justice (DOJ) changed its position with respect to the enforceability of class action waivers in


As If Leave Laws Aren’t Complicated Enough - Don’t Forget That Leave Can Be a Reasonable Accommodation
  • Foley & Lardner LLP
  • USA
  • July 24 2017

The myriad of leave laws and requirements often make employee leave requests an area of confusion, concern and risk for employers. If an employee has


Proposed Rule Would Slash Medicare Payment for 340B Drugs
  • Foley & Lardner LLP
  • USA
  • July 20 2017

The Centers for Medicare and Medicaid Services (CMS) has proposed reducing the Medicare payment rate to hospitals for most separately payable drugs


STRONGER Patents Act of 2017 Disadvantages Domestic Manufacturers
  • Foley & Lardner LLP
  • USA
  • July 20 2017

In late June, Senators Coons, Cotton, Durbin, and Hirono introduced the STRONGER Patents Act of 2017. The Act includes provisions that seek to


CFPB Loses Borders Case: the Court Construes RESPA’s Statutory ABA Exemption according to its Plain Language
  • Foley & Lardner LLP
  • USA
  • July 19 2017

On July 12, 2017, a federal district court in Kentucky issued a summary judgment ruling for the defense in the ongoing Borders & Borders case1


Seventh Circuit Underscores Important Role for Pre-Certification Challenges to Expert Witnesses
  • Foley & Lardner LLP
  • USA
  • July 19 2017

In order to certify a class action, it is the Plaintiff’s burden to prove that all of the requirements of Rule 23 of the Federal Rules of Civil


Vermont’s New Telemedicine Law Expands Insurance Coverage, Bans Recording
  • Foley & Lardner LLP
  • USA
  • July 19 2017

Vermont health care providers and patients can now enjoy a revamped, and significantly improved, telehealth commercial insurance coverage law